From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Neurology>
  4. Summary and Comment

Is Sporadic Creutzfeldt-Jakob Disease Systemic?

These findings suggest that sCJD poses more risk -- but also provides more diagnostic opportunity -- than previously realized.

The common perception about sporadic Creutzfeldt-Jakob disease (sCJD) is that the disease begins and ends in the brain. However, researchers now report the presence of prions or scrapie prion protein (PrPSc) in extraneural organs of patients with sCJD.

The authors examined the autopsied organs from 36 patients with proven sCJD by using phosphotungstic acid precipitation to enrich PrPSc preparations by up to three orders of magnitude. PrPSc was found in 10 of 28 spleen specimens and in 8 of 32 skeletal-muscle specimens. Three patients had PrPSc in both spleen and muscle. The authors estimate that the levels of PrPSc found in extraneural organs were about 10,000-fold lower than levels found in the brain. The presence of extraneural PrPSc correlated with two uncommon phenotypes of sCJD that are characterized by long disease duration. The authors speculate that the long duration of illness in these phenotypes increases the likelihood of spillover of cerebral PrPSc to extraneural areas.

Comment: This study forces us to rethink sCJD and raises new concerns about its transmission. The presence of PrPSc in peripheral tissues raises the possibility of an increased risk for iatrogenic transmission, but it also increases the feasibility of developing a blood diagnostic test. These results also call into question previous findings that ruled out the presence of PrPSc in skeletal muscle of bovine spongiform encephalopathy (BSE)-affected cattle and suggest that such specimens should be reexamined with modern, more sensitive techniques. A clear understanding of prion-protein distribution in humans and in animals is critically needed to provide efficient disease protection. The recent discovery of BSE in North America gives these issues added urgency.

— Wen-Quan Zou, MD, PhD, and Pierluigi Gambetti, MD

Dr. Zou is Instructor, Division of Neuropathology, Case Western Reserve University and National Prion Disease Pathology Surveillance Center, Cleveland. Dr. Gambetti is Professor and Director, Division of Neuropathology, Case Western Reserve University and National Prion Disease Pathology Surveillance Center, Cleveland.

Published in Journal Watch Neurology February 26, 2004

Citation(s):

Glatzel M et al. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003 Nov 6; 349:1812-20.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2004. Massachusetts Medical Society. All rights reserved.